Nanophase reports record Q2 revenue $13M (+10% YoY) and net income $856K (+157%)

SOLESENCE, INC.

2024-Q2 EPS reported $0.03 revenue$22,914,000

Q2 revenue $13M vs $11.9M in Q2 2023 (+10%); Solésence revenue $11.2M (+44% YoY).
First half 2024 net income $1.7M vs loss $0.8M in H1 2023; gross profit $7.3M (+26%).
Second half revenue expected to exceed first half by more than 20% per management.
Won third consecutive Cosmopack North America Formulation Award for Lip Oil SPF 40+.
Q2 net income $856K vs $333K in prior year period, a 157% increase.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.